Megestrol acetate inhibits the expression of cytoplasmic aromatase through nuclear C/EBPβ in reperfusion injury-induced ischemic rat hippocampus
- 1 March 2011
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 654 (3) , 217-225
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Neuroprotective effects of estrogens following ischemic strokeFrontiers in Neuroendocrinology, 2009
- Estradiol Is a Potent Protective, Restorative, and Trophic Factor after Brain InjurySeminars in Reproductive Medicine, 2009
- Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damageNeurochemistry International, 2007
- A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose FibroblastsJournal of Biological Chemistry, 2006
- Microarray Analysis Supports a Role for CCAAT/Enhancer-binding Protein-β in Brain InjuryJournal of Biological Chemistry, 2004
- Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromataseJournal of Neurobiology, 2003
- 17β-Estradiol Protects Neurons from Ischemic Damage and Attenuates Accumulation of Extracellular Excitatory Amino AcidsAnesthesia & Analgesia, 2001
- CCAAT/Enhancer Binding Protein β Is a Neuronal Transcriptional Regulator Activated by Nerve Growth Factor Receptor SignalingJournal of Neurochemistry, 1998
- 17-β Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death in VitroBiochemical and Biophysical Research Communications, 1995
- Melengestrol acetate and megestrol acetate are prostatic tumor inhibiting agentsBiochemistry and Cell Biology, 1990